Please use this identifier to cite or link to this item:
|Title:||Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma||Authors:||Bou Zerdan, Maroun
Bou Zerdan, Morgan
|Affiliations:||Faculty of Medicine||Keywords:||Fibroblasts
Pancreatic ductal adenocarcinoma
Single cell RNA sequencing
|Issue Date:||2022-01-22||Publisher:||National Library of Medicine||Part of:||Cancers||Volume:||14||Issue:||19||Abstract:||
Pancreatic cancer has a very low survival rate for several reasons. One of those is primarily due to the difficulty in diagnosing it at an early stage. For this reason, it is important to refine our understanding of this disease to guide the development of new diagnostic and therapeutic modalities to combat this fatal illness. Here we attempt to provide a review of current progress in utilizing single-cell RNA sequencing (scRNA-seq) techniques in the molecular profiling of pancreatic ductal adenocarcinoma.
Pancreatic ductal adenocarcinoma is a malignancy with a high mortality rate. It exhibits significant heterogeneity in metabolic pathways which are associated with its progression. In this review, we discuss the role of single cell RNA sequencing in unraveling the metabolic and clinical features of these highly malignant tumors.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/6136||ISSN:||2072-6694||DOI:||10.3390/cancers14194589||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Faculty of Medicine|
Show full item record
checked on Nov 28, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.